EpiCept's common stock included on a list of preliminary additions to Russell Microcap Index

NewsGuard 100/100 Score

Regulatory News:

“We are pleased that EpiCept stock can benefit from the wider exposure offered by its preliminary addition to the index”

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Company's common stock has been included on a list of preliminary additions to the Russell Microcap® Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.

"Inclusion in this index would represent an important step in EpiCept's evolution, as the equity markets recognize and reflect our growth into a commercial enterprise," said Jack Talley, EpiCept's president and chief executive officer. "We are pleased that EpiCept stock can benefit from the wider exposure offered by its preliminary addition to the index," he added.

The Russell Microcap Index measures the performance of the microcap segment of the U.S. equity market and is comprised of the smallest 1,000 companies in the Russell 3000® Index, plus the next smallest 1,000 companies. The Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for passive and active investment strategies. The indexes are reconstituted annually.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.